Whitehawk Therapeutics Inc
Whitehawk Therapeutics Inc (WHWK) Stock Competitors & Peer Comparison
See (WHWK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WHWK | $3.55 | +8.23% | 162.8M | -10.45 | -$0.33 | N/A |
| VRTX | $449.41 | +1.41% | 113.4B | 29.12 | $15.33 | N/A |
| REGN | $777.41 | +3.75% | 80.3B | 18.64 | $41.46 | +0.46% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $751.92 | +6.76% | 45.2B | 37.28 | $19.59 | N/A |
| ALNY | $330.71 | +4.63% | 43.9B | 142.63 | $2.32 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| INSM | $164.29 | +7.15% | 35.2B | -25.43 | -$6.43 | N/A |
| UTHR | $573.71 | -2.49% | 26B | 21.27 | $27.87 | N/A |
| BNTX | $90.41 | +6.05% | 22.3B | -16.40 | -$5.42 | N/A |
Stock Comparison
WHWK vs VRTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, VRTX has a market cap of 113.4B. Regarding current trading prices, WHWK is priced at $3.55, while VRTX trades at $449.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas VRTX's P/E ratio is 29.12. In terms of profitability, WHWK's ROE is -0.12%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, WHWK is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check VRTX's competition here
WHWK vs REGN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, REGN has a market cap of 80.3B. Regarding current trading prices, WHWK is priced at $3.55, while REGN trades at $777.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas REGN's P/E ratio is 18.64. In terms of profitability, WHWK's ROE is -0.12%, compared to REGN's ROE of +0.15%. Regarding short-term risk, WHWK is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check REGN's competition here
WHWK vs VRNA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, WHWK is priced at $3.55, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas VRNA's P/E ratio is -102.80. In terms of profitability, WHWK's ROE is -0.12%, compared to VRNA's ROE of -0.30%. Regarding short-term risk, WHWK is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check VRNA's competition here
WHWK vs ARGX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ARGX has a market cap of 45.2B. Regarding current trading prices, WHWK is priced at $3.55, while ARGX trades at $751.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ARGX's P/E ratio is 37.28. In terms of profitability, WHWK's ROE is -0.12%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, WHWK is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ARGX's competition here
WHWK vs ALNY Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ALNY has a market cap of 43.9B. Regarding current trading prices, WHWK is priced at $3.55, while ALNY trades at $330.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ALNY's P/E ratio is 142.63. In terms of profitability, WHWK's ROE is -0.12%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, WHWK is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ALNY's competition here
WHWK vs SGEN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, WHWK is priced at $3.55, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas SGEN's P/E ratio is -57.19. In terms of profitability, WHWK's ROE is -0.12%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, WHWK is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check SGEN's competition here
WHWK vs INSM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, INSM has a market cap of 35.2B. Regarding current trading prices, WHWK is priced at $3.55, while INSM trades at $164.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas INSM's P/E ratio is -25.43. In terms of profitability, WHWK's ROE is -0.12%, compared to INSM's ROE of -1.68%. Regarding short-term risk, WHWK is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check INSM's competition here
WHWK vs UTHR Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, UTHR has a market cap of 26B. Regarding current trading prices, WHWK is priced at $3.55, while UTHR trades at $573.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas UTHR's P/E ratio is 21.27. In terms of profitability, WHWK's ROE is -0.12%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, WHWK is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check UTHR's competition here
WHWK vs BNTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BNTX has a market cap of 22.3B. Regarding current trading prices, WHWK is priced at $3.55, while BNTX trades at $90.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BNTX's P/E ratio is -16.40. In terms of profitability, WHWK's ROE is -0.12%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, WHWK is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BNTX's competition here
WHWK vs RPRX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RPRX has a market cap of 20.6B. Regarding current trading prices, WHWK is priced at $3.55, while RPRX trades at $48.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RPRX's P/E ratio is 26.95. In terms of profitability, WHWK's ROE is -0.12%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, WHWK is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RPRX's competition here
WHWK vs BGNE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, WHWK is priced at $3.55, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BGNE's P/E ratio is -22.55. In terms of profitability, WHWK's ROE is -0.12%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, WHWK is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BGNE's competition here
WHWK vs MRNA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MRNA has a market cap of 20.1B. Regarding current trading prices, WHWK is priced at $3.55, while MRNA trades at $51.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MRNA's P/E ratio is -7.00. In terms of profitability, WHWK's ROE is -0.12%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, WHWK is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MRNA's competition here
WHWK vs ROIV Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ROIV has a market cap of 19.8B. Regarding current trading prices, WHWK is priced at $3.55, while ROIV trades at $28.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ROIV's P/E ratio is -23.68. In terms of profitability, WHWK's ROE is -0.12%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, WHWK is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ROIV's competition here
WHWK vs RVMD Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RVMD has a market cap of 19.3B. Regarding current trading prices, WHWK is priced at $3.55, while RVMD trades at $97.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RVMD's P/E ratio is -16.34. In terms of profitability, WHWK's ROE is -0.12%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, WHWK is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RVMD's competition here
WHWK vs DNA-WT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, WHWK is priced at $3.55, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, WHWK's ROE is -0.12%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, WHWK is more volatile compared to DNA-WT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check DNA-WT's competition here
WHWK vs INCY Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, INCY has a market cap of 18.7B. Regarding current trading prices, WHWK is priced at $3.55, while INCY trades at $94.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas INCY's P/E ratio is 14.68. In terms of profitability, WHWK's ROE is -0.12%, compared to INCY's ROE of +0.29%. Regarding short-term risk, WHWK is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check INCY's competition here
WHWK vs GMAB Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, GMAB has a market cap of 16.5B. Regarding current trading prices, WHWK is priced at $3.55, while GMAB trades at $27.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas GMAB's P/E ratio is 17.42. In terms of profitability, WHWK's ROE is -0.12%, compared to GMAB's ROE of +0.11%. Regarding short-term risk, WHWK is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check GMAB's competition here
WHWK vs BBIO Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BBIO has a market cap of 14.4B. Regarding current trading prices, WHWK is priced at $3.55, while BBIO trades at $74.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BBIO's P/E ratio is -19.65. In terms of profitability, WHWK's ROE is -0.12%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, WHWK is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BBIO's competition here
WHWK vs SMMT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, SMMT has a market cap of 14.1B. Regarding current trading prices, WHWK is priced at $3.55, while SMMT trades at $18.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas SMMT's P/E ratio is -13.17. In terms of profitability, WHWK's ROE is -0.12%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, WHWK is more volatile compared to SMMT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check SMMT's competition here
WHWK vs ASND Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ASND has a market cap of 14B. Regarding current trading prices, WHWK is priced at $3.55, while ASND trades at $229.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ASND's P/E ratio is -52.70. In terms of profitability, WHWK's ROE is -0.12%, compared to ASND's ROE of +1.28%. Regarding short-term risk, WHWK is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ASND's competition here
WHWK vs KRTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, WHWK is priced at $3.55, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas KRTX's P/E ratio is -28.09. In terms of profitability, WHWK's ROE is -0.12%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, WHWK is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check KRTX's competition here
WHWK vs IONS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, IONS has a market cap of 12.4B. Regarding current trading prices, WHWK is priced at $3.55, while IONS trades at $76.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas IONS's P/E ratio is -31.55. In terms of profitability, WHWK's ROE is -0.12%, compared to IONS's ROE of -0.69%. Regarding short-term risk, WHWK is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check IONS's competition here
WHWK vs MDGL Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MDGL has a market cap of 12B. Regarding current trading prices, WHWK is priced at $3.55, while MDGL trades at $530.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MDGL's P/E ratio is -40.67. In terms of profitability, WHWK's ROE is -0.12%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, WHWK is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MDGL's competition here
WHWK vs JAZZ Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, JAZZ has a market cap of 11.6B. Regarding current trading prices, WHWK is priced at $3.55, while JAZZ trades at $189.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas JAZZ's P/E ratio is -32.37. In terms of profitability, WHWK's ROE is -0.12%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, WHWK is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check JAZZ's competition here
WHWK vs EXEL Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, EXEL has a market cap of 11.5B. Regarding current trading prices, WHWK is priced at $3.55, while EXEL trades at $44.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas EXEL's P/E ratio is 15.43. In terms of profitability, WHWK's ROE is -0.12%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, WHWK is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check EXEL's competition here
WHWK vs RNAM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, WHWK is priced at $3.55, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RNAM's P/E ratio is -17.39. In terms of profitability, WHWK's ROE is -0.12%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, WHWK is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RNAM's competition here
WHWK vs BMRN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BMRN has a market cap of 10.9B. Regarding current trading prices, WHWK is priced at $3.55, while BMRN trades at $57.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BMRN's P/E ratio is 31.38. In terms of profitability, WHWK's ROE is -0.12%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, WHWK is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BMRN's competition here
WHWK vs RXDX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, WHWK is priced at $3.55, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RXDX's P/E ratio is -56.47. In terms of profitability, WHWK's ROE is -0.12%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, WHWK is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RXDX's competition here
WHWK vs ARWR Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ARWR has a market cap of 8.8B. Regarding current trading prices, WHWK is priced at $3.55, while ARWR trades at $64.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ARWR's P/E ratio is 39.19. In terms of profitability, WHWK's ROE is -0.12%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, WHWK is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ARWR's competition here
WHWK vs IMGN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, WHWK is priced at $3.55, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas IMGN's P/E ratio is -111.55. In terms of profitability, WHWK's ROE is -0.12%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, WHWK is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check IMGN's competition here
WHWK vs AXSM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, AXSM has a market cap of 8.6B. Regarding current trading prices, WHWK is priced at $3.55, while AXSM trades at $173.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas AXSM's P/E ratio is -46.05. In terms of profitability, WHWK's ROE is -0.12%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, WHWK is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check AXSM's competition here
WHWK vs PCVX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, PCVX has a market cap of 8.4B. Regarding current trading prices, WHWK is priced at $3.55, while PCVX trades at $59.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas PCVX's P/E ratio is -10.32. In terms of profitability, WHWK's ROE is -0.12%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, WHWK is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check PCVX's competition here
WHWK vs BPMC Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, WHWK is priced at $3.55, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BPMC's P/E ratio is -51.58. In terms of profitability, WHWK's ROE is -0.12%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, WHWK is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BPMC's competition here
WHWK vs CERE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, WHWK is priced at $3.55, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CERE's P/E ratio is -16.47. In terms of profitability, WHWK's ROE is -0.12%, compared to CERE's ROE of -0.72%. Regarding short-term risk, WHWK is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CERE's competition here
WHWK vs TECH Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, TECH has a market cap of 8.2B. Regarding current trading prices, WHWK is priced at $3.55, while TECH trades at $53.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas TECH's P/E ratio is 98.60. In terms of profitability, WHWK's ROE is -0.12%, compared to TECH's ROE of +0.04%. Regarding short-term risk, WHWK is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check TECH's competition here
WHWK vs CYTK Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CYTK has a market cap of 8.1B. Regarding current trading prices, WHWK is priced at $3.55, while CYTK trades at $66.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CYTK's P/E ratio is -10.08. In terms of profitability, WHWK's ROE is -0.12%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, WHWK is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CYTK's competition here
WHWK vs IBRX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, IBRX has a market cap of 7.9B. Regarding current trading prices, WHWK is priced at $3.55, while IBRX trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas IBRX's P/E ratio is -20.18. In terms of profitability, WHWK's ROE is -0.12%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, WHWK is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for WHWK.Check IBRX's competition here
WHWK vs HALO Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, HALO has a market cap of 7.6B. Regarding current trading prices, WHWK is priced at $3.55, while HALO trades at $65.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas HALO's P/E ratio is 25.25. In terms of profitability, WHWK's ROE is -0.12%, compared to HALO's ROE of +0.93%. Regarding short-term risk, WHWK is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check HALO's competition here
WHWK vs KRYS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, KRYS has a market cap of 7.6B. Regarding current trading prices, WHWK is priced at $3.55, while KRYS trades at $261.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas KRYS's P/E ratio is 37.71. In terms of profitability, WHWK's ROE is -0.12%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, WHWK is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check KRYS's competition here
WHWK vs NUVL Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, NUVL has a market cap of 7.5B. Regarding current trading prices, WHWK is priced at $3.55, while NUVL trades at $105.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas NUVL's P/E ratio is -17.51. In terms of profitability, WHWK's ROE is -0.12%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, WHWK is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check NUVL's competition here
WHWK vs MTSR Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, WHWK is priced at $3.55, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MTSR's P/E ratio is -23.58. In terms of profitability, WHWK's ROE is -0.12%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, WHWK is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MTSR's competition here
WHWK vs ABVX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ABVX has a market cap of 7.3B. Regarding current trading prices, WHWK is priced at $3.55, while ABVX trades at $115.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ABVX's P/E ratio is -19.96. In terms of profitability, WHWK's ROE is -0.12%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, WHWK is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ABVX's competition here
WHWK vs MRUS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, WHWK is priced at $3.55, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MRUS's P/E ratio is -17.05. In terms of profitability, WHWK's ROE is -0.12%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, WHWK is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MRUS's competition here
WHWK vs PRAX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, PRAX has a market cap of 6.8B. Regarding current trading prices, WHWK is priced at $3.55, while PRAX trades at $331.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas PRAX's P/E ratio is -23.90. In terms of profitability, WHWK's ROE is -0.12%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, WHWK is more volatile compared to PRAX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check PRAX's competition here
WHWK vs KYMR Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, KYMR has a market cap of 6.8B. Regarding current trading prices, WHWK is priced at $3.55, while KYMR trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas KYMR's P/E ratio is -22.57. In terms of profitability, WHWK's ROE is -0.12%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, WHWK is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check KYMR's competition here
WHWK vs PTGX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, PTGX has a market cap of 6.7B. Regarding current trading prices, WHWK is priced at $3.55, while PTGX trades at $104.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas PTGX's P/E ratio is -51.41. In terms of profitability, WHWK's ROE is -0.12%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, WHWK is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check PTGX's competition here
WHWK vs ACLX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, WHWK is priced at $3.55, while ACLX trades at $114.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ACLX's P/E ratio is -28.21. In terms of profitability, WHWK's ROE is -0.12%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, WHWK is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ACLX's competition here
WHWK vs RETA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, WHWK is priced at $3.55, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RETA's P/E ratio is -66.29. In terms of profitability, WHWK's ROE is -0.12%, compared to RETA's ROE of +0.47%. Regarding short-term risk, WHWK is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RETA's competition here
WHWK vs BLTE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, BLTE has a market cap of 6.3B. Regarding current trading prices, WHWK is priced at $3.55, while BLTE trades at $166.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas BLTE's P/E ratio is -69.02. In terms of profitability, WHWK's ROE is -0.12%, compared to BLTE's ROE of -0.43%. Regarding short-term risk, WHWK is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check BLTE's competition here
WHWK vs COGT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, COGT has a market cap of 6.2B. Regarding current trading prices, WHWK is priced at $3.55, while COGT trades at $35.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas COGT's P/E ratio is -17.82. In terms of profitability, WHWK's ROE is -0.12%, compared to COGT's ROE of -1.00%. Regarding short-term risk, WHWK is less volatile compared to COGT. This indicates potentially lower risk in terms of short-term price fluctuations for WHWK.Check COGT's competition here
WHWK vs RYTM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RYTM has a market cap of 5.9B. Regarding current trading prices, WHWK is priced at $3.55, while RYTM trades at $88.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RYTM's P/E ratio is -27.96. In terms of profitability, WHWK's ROE is -0.12%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, WHWK is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RYTM's competition here
WHWK vs ALKS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ALKS has a market cap of 5.9B. Regarding current trading prices, WHWK is priced at $3.55, while ALKS trades at $35.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ALKS's P/E ratio is 24.75. In terms of profitability, WHWK's ROE is -0.12%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, WHWK is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ALKS's competition here
WHWK vs CGON Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CGON has a market cap of 5.7B. Regarding current trading prices, WHWK is priced at $3.55, while CGON trades at $67.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CGON's P/E ratio is -32.54. In terms of profitability, WHWK's ROE is -0.12%, compared to CGON's ROE of -0.23%. Regarding short-term risk, WHWK is more volatile compared to CGON. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CGON's competition here
WHWK vs SRRK Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, SRRK has a market cap of 5.6B. Regarding current trading prices, WHWK is priced at $3.55, while SRRK trades at $49.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas SRRK's P/E ratio is -14.94. In terms of profitability, WHWK's ROE is -0.12%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, WHWK is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check SRRK's competition here
WHWK vs PTCT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, PTCT has a market cap of 5.6B. Regarding current trading prices, WHWK is priced at $3.55, while PTCT trades at $69.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas PTCT's P/E ratio is 7.94. In terms of profitability, WHWK's ROE is -0.12%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, WHWK is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check PTCT's competition here
WHWK vs CDTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, WHWK is priced at $3.55, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CDTX's P/E ratio is -19.77. In terms of profitability, WHWK's ROE is -0.12%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, WHWK is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CDTX's competition here
WHWK vs ABCM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, WHWK is priced at $3.55, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, WHWK's ROE is -0.12%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, WHWK is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ABCM's competition here
WHWK vs CELC Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CELC has a market cap of 5.5B. Regarding current trading prices, WHWK is priced at $3.55, while CELC trades at $113.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CELC's P/E ratio is -30.12. In terms of profitability, WHWK's ROE is -0.12%, compared to CELC's ROE of -2.03%. Regarding short-term risk, WHWK is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CELC's competition here
WHWK vs ISEE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, WHWK is priced at $3.55, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ISEE's P/E ratio is -22.44. In terms of profitability, WHWK's ROE is -0.12%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, WHWK is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ISEE's competition here
WHWK vs FBIOX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, FBIOX has a market cap of 5.4B. Regarding current trading prices, WHWK is priced at $3.55, while FBIOX trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas FBIOX's P/E ratio is N/A. In terms of profitability, WHWK's ROE is -0.12%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, WHWK is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check FBIOX's competition here
WHWK vs CNTA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CNTA has a market cap of 5.3B. Regarding current trading prices, WHWK is priced at $3.55, while CNTA trades at $39.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CNTA's P/E ratio is -21.02. In terms of profitability, WHWK's ROE is -0.12%, compared to CNTA's ROE of -0.68%. Regarding short-term risk, WHWK is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CNTA's competition here
WHWK vs TGTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, TGTX has a market cap of 5.3B. Regarding current trading prices, WHWK is priced at $3.55, while TGTX trades at $34.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas TGTX's P/E ratio is 11.99. In terms of profitability, WHWK's ROE is -0.12%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, WHWK is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check TGTX's competition here
WHWK vs APLS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, APLS has a market cap of 5.1B. Regarding current trading prices, WHWK is priced at $3.55, while APLS trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas APLS's P/E ratio is 223.50. In terms of profitability, WHWK's ROE is -0.12%, compared to APLS's ROE of +0.08%. Regarding short-term risk, WHWK is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check APLS's competition here
WHWK vs IMVT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, IMVT has a market cap of 5.1B. Regarding current trading prices, WHWK is priced at $3.55, while IMVT trades at $25.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas IMVT's P/E ratio is -9.30. In terms of profitability, WHWK's ROE is -0.12%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, WHWK is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check IMVT's competition here
WHWK vs CAI Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CAI has a market cap of 5.1B. Regarding current trading prices, WHWK is priced at $3.55, while CAI trades at $18.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CAI's P/E ratio is -5.55. In terms of profitability, WHWK's ROE is -0.12%, compared to CAI's ROE of +0.25%. Regarding short-term risk, WHWK is more volatile compared to CAI. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CAI's competition here
WHWK vs ERAS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ERAS has a market cap of 5B. Regarding current trading prices, WHWK is priced at $3.55, while ERAS trades at $16.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ERAS's P/E ratio is -36.77. In terms of profitability, WHWK's ROE is -0.12%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, WHWK is more volatile compared to ERAS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ERAS's competition here
WHWK vs TERN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, TERN has a market cap of 4.7B. Regarding current trading prices, WHWK is priced at $3.55, while TERN trades at $52.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas TERN's P/E ratio is -51.69. In terms of profitability, WHWK's ROE is -0.12%, compared to TERN's ROE of -0.20%. Regarding short-term risk, WHWK is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check TERN's competition here
WHWK vs APGE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, APGE has a market cap of 4.7B. Regarding current trading prices, WHWK is priced at $3.55, while APGE trades at $85.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas APGE's P/E ratio is -19.95. In terms of profitability, WHWK's ROE is -0.12%, compared to APGE's ROE of -0.37%. Regarding short-term risk, WHWK is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check APGE's competition here
WHWK vs MIRM Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MIRM has a market cap of 4.6B. Regarding current trading prices, WHWK is priced at $3.55, while MIRM trades at $95.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MIRM's P/E ratio is -196.55. In terms of profitability, WHWK's ROE is -0.12%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, WHWK is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MIRM's competition here
WHWK vs XENE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, XENE has a market cap of 4.6B. Regarding current trading prices, WHWK is priced at $3.55, while XENE trades at $57.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas XENE's P/E ratio is -13.34. In terms of profitability, WHWK's ROE is -0.12%, compared to XENE's ROE of -0.56%. Regarding short-term risk, WHWK is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check XENE's competition here
WHWK vs CRSP Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CRSP has a market cap of 4.6B. Regarding current trading prices, WHWK is priced at $3.55, while CRSP trades at $49.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CRSP's P/E ratio is -7.35. In terms of profitability, WHWK's ROE is -0.12%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, WHWK is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CRSP's competition here
WHWK vs FOLD Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, WHWK is priced at $3.55, while FOLD trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas FOLD's P/E ratio is -160.67. In terms of profitability, WHWK's ROE is -0.12%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, WHWK is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check FOLD's competition here
WHWK vs AKRO Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, WHWK is priced at $3.55, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas AKRO's P/E ratio is -14.57. In terms of profitability, WHWK's ROE is -0.12%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, WHWK is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check AKRO's competition here
WHWK vs ALPN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, WHWK is priced at $3.55, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ALPN's P/E ratio is -101.52. In terms of profitability, WHWK's ROE is -0.12%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, WHWK is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ALPN's competition here
WHWK vs CORT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CORT has a market cap of 4.3B. Regarding current trading prices, WHWK is priced at $3.55, while CORT trades at $42.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CORT's P/E ratio is 49.16. In terms of profitability, WHWK's ROE is -0.12%, compared to CORT's ROE of +0.15%. Regarding short-term risk, WHWK is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CORT's competition here
WHWK vs OPT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, WHWK is priced at $3.55, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas OPT's P/E ratio is -1.52. In terms of profitability, WHWK's ROE is -0.12%, compared to OPT's ROE of +0.88%. Regarding short-term risk, WHWK is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check OPT's competition here
WHWK vs MRTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, WHWK is priced at $3.55, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas MRTX's P/E ratio is -4.82. In terms of profitability, WHWK's ROE is -0.12%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, WHWK is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check MRTX's competition here
WHWK vs LGND Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, LGND has a market cap of 4B. Regarding current trading prices, WHWK is priced at $3.55, while LGND trades at $204.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas LGND's P/E ratio is 32.62. In terms of profitability, WHWK's ROE is -0.12%, compared to LGND's ROE of +0.14%. Regarding short-term risk, WHWK is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check LGND's competition here
WHWK vs CRNX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CRNX has a market cap of 3.8B. Regarding current trading prices, WHWK is priced at $3.55, while CRNX trades at $36.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CRNX's P/E ratio is -7.34. In terms of profitability, WHWK's ROE is -0.12%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, WHWK is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CRNX's competition here
WHWK vs ACAD Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ACAD has a market cap of 3.8B. Regarding current trading prices, WHWK is priced at $3.55, while ACAD trades at $22.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ACAD's P/E ratio is 9.68. In terms of profitability, WHWK's ROE is -0.12%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, WHWK is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ACAD's competition here
WHWK vs VKTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, VKTX has a market cap of 3.8B. Regarding current trading prices, WHWK is priced at $3.55, while VKTX trades at $33.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas VKTX's P/E ratio is -10.20. In terms of profitability, WHWK's ROE is -0.12%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, WHWK is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check VKTX's competition here
WHWK vs RYZB Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, WHWK is priced at $3.55, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas RYZB's P/E ratio is -57.86. In terms of profitability, WHWK's ROE is -0.12%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, WHWK is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check RYZB's competition here
WHWK vs CBAY Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, WHWK is priced at $3.55, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CBAY's P/E ratio is -32.81. In terms of profitability, WHWK's ROE is -0.12%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, WHWK is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CBAY's competition here
WHWK vs NAMS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, NAMS has a market cap of 3.7B. Regarding current trading prices, WHWK is priced at $3.55, while NAMS trades at $32.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas NAMS's P/E ratio is -18.61. In terms of profitability, WHWK's ROE is -0.12%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, WHWK is more volatile compared to NAMS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check NAMS's competition here
WHWK vs KNSA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, KNSA has a market cap of 3.6B. Regarding current trading prices, WHWK is priced at $3.55, while KNSA trades at $48.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas KNSA's P/E ratio is 64.20. In terms of profitability, WHWK's ROE is -0.12%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, WHWK is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check KNSA's competition here
WHWK vs SWTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, WHWK is priced at $3.55, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas SWTX's P/E ratio is -13.78. In terms of profitability, WHWK's ROE is -0.12%, compared to SWTX's ROE of -0.45%. Regarding short-term risk, WHWK is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check SWTX's competition here
WHWK vs EWTX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, EWTX has a market cap of 3.4B. Regarding current trading prices, WHWK is priced at $3.55, while EWTX trades at $32.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas EWTX's P/E ratio is -19.33. In terms of profitability, WHWK's ROE is -0.12%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, WHWK is more volatile compared to EWTX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check EWTX's competition here
WHWK vs LEGN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, LEGN has a market cap of 3.3B. Regarding current trading prices, WHWK is priced at $3.55, while LEGN trades at $19.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas LEGN's P/E ratio is -11.17. In terms of profitability, WHWK's ROE is -0.12%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, WHWK is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check LEGN's competition here
WHWK vs LQDA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, LQDA has a market cap of 3.3B. Regarding current trading prices, WHWK is priced at $3.55, while LQDA trades at $37.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas LQDA's P/E ratio is -47.17. In terms of profitability, WHWK's ROE is -0.12%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, WHWK is more volatile compared to LQDA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check LQDA's competition here
WHWK vs TLX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, TLX has a market cap of 3.2B. Regarding current trading prices, WHWK is priced at $3.55, while TLX trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas TLX's P/E ratio is -478.50. In terms of profitability, WHWK's ROE is -0.12%, compared to TLX's ROE of -0.02%. Regarding short-term risk, WHWK is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check TLX's competition here
WHWK vs DNTH Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, DNTH has a market cap of 3.2B. Regarding current trading prices, WHWK is priced at $3.55, while DNTH trades at $86.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas DNTH's P/E ratio is -19.98. In terms of profitability, WHWK's ROE is -0.12%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, WHWK is more volatile compared to DNTH. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check DNTH's competition here
WHWK vs SYRE Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, SYRE has a market cap of 3B. Regarding current trading prices, WHWK is priced at $3.55, while SYRE trades at $49.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas SYRE's P/E ratio is -25.47. In terms of profitability, WHWK's ROE is -0.12%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, WHWK is more volatile compared to SYRE. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check SYRE's competition here
WHWK vs DNLI Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, DNLI has a market cap of 3B. Regarding current trading prices, WHWK is priced at $3.55, while DNLI trades at $19.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas DNLI's P/E ratio is -6.46. In terms of profitability, WHWK's ROE is -0.12%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, WHWK is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check DNLI's competition here
WHWK vs CPRX Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, CPRX has a market cap of 3B. Regarding current trading prices, WHWK is priced at $3.55, while CPRX trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas CPRX's P/E ratio is 14.74. In terms of profitability, WHWK's ROE is -0.12%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, WHWK is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check CPRX's competition here
WHWK vs DYN Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, DYN has a market cap of 3B. Regarding current trading prices, WHWK is priced at $3.55, while DYN trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas DYN's P/E ratio is -5.22. In terms of profitability, WHWK's ROE is -0.12%, compared to DYN's ROE of -0.61%. Regarding short-term risk, WHWK is more volatile compared to DYN. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check DYN's competition here
WHWK vs TARS Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, TARS has a market cap of 3B. Regarding current trading prices, WHWK is priced at $3.55, while TARS trades at $70.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas TARS's P/E ratio is -44.12. In terms of profitability, WHWK's ROE is -0.12%, compared to TARS's ROE of -0.20%. Regarding short-term risk, WHWK is more volatile compared to TARS. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check TARS's competition here
WHWK vs IDYA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, IDYA has a market cap of 2.9B. Regarding current trading prices, WHWK is priced at $3.55, while IDYA trades at $33.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas IDYA's P/E ratio is -26.03. In terms of profitability, WHWK's ROE is -0.12%, compared to IDYA's ROE of -0.11%. Regarding short-term risk, WHWK is more volatile compared to IDYA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check IDYA's competition here
WHWK vs ARQT Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, ARQT has a market cap of 2.9B. Regarding current trading prices, WHWK is priced at $3.55, while ARQT trades at $24.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas ARQT's P/E ratio is -181.23. In terms of profitability, WHWK's ROE is -0.12%, compared to ARQT's ROE of -0.10%. Regarding short-term risk, WHWK is more volatile compared to ARQT. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check ARQT's competition here
WHWK vs VERA Comparison April 2026
WHWK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WHWK stands at 162.8M. In comparison, VERA has a market cap of 2.9B. Regarding current trading prices, WHWK is priced at $3.55, while VERA trades at $41.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WHWK currently has a P/E ratio of -10.45, whereas VERA's P/E ratio is -8.63. In terms of profitability, WHWK's ROE is -0.12%, compared to VERA's ROE of -0.60%. Regarding short-term risk, WHWK is more volatile compared to VERA. This indicates potentially higher risk in terms of short-term price fluctuations for WHWK.Check VERA's competition here